Sagent Pharmaceuticals, Inc. 4
4 · Sagent Pharmaceuticals, Inc. · Filed Feb 23, 2016
Insider Transaction Report
Form 4
Krizman Anthony
Director
Transactions
- Exercise/Conversion
Common Stock
2016-02-21+760→ 5,840 total - Exercise/Conversion
Restricted Stock Units
2016-02-21−760→ 760 total→ Common Stock (760 underlying) - Exercise/Conversion
Restricted Stock Units
2016-02-22−567→ 0 total→ Common Stock (567 underlying) - Exercise/Conversion
Common Stock
2016-02-22+567→ 6,407 total - Award
Restricted Stock Units
2016-02-22+8,556→ 8,556 total→ Common Stock (8,556 underlying)
Footnotes (5)
- [F1]Vesting of restricted stock units.
- [F2]Each restricted stock unit represents a contingent right to receive one share of SGNT common stock.
- [F3]The restricted stock units vest in four equal annual installments beginning on February 21, 2014. Vested shares will generally be delivered to the reporting person within 30 days following the vesting date.
- [F4]The restricted stock units vest in four equal annual installments beginning on February 22, 2013. Vested shares will generally be delivered to the reporting person within 30 days following the vesting date.
- [F5]The restricted stock units vest in four equal annual installments beginning on February 22, 2017. Vested shares will generally be delivered to the reporting person within 30 days following the vesting date.